about us

technology strategy

partnership opportunities

careers

contact

Molecular Diagnostics
Care with certainty.^SM

IntelligentMDx develops and manufactures tests, under regulatory compliance, for a broad range of molecular based systems for use in clinical diagnostics, drug development and applied science applications. Our mission is to rapidly translate the needs of the clinician, patient and partners into very specific, highly sensitive, robust clinically impactful tests, thus enabling caregivers worldwide to provide care with certainty^SM.

IntelligentMDx's competitive advantage incorporates intelligent software with assay development and manufacturing expertise within a Quality System compliant with both ISO and FDA current regulations. Our uniquely integrated modular test development process provides clinically impactful and novel molecular testing solutions. The company is working to use its proprietary "symptom-based diagnostics" approach for disease detection. Our goal is to provide the end users with "smart" tests that detect several related diseases at once — more quickly and more economically than current standard individual tests. The quality and breadth of our product candidate pipeline, platform-agnostic approach, scientific team and strategic collaborations and partnerships is enabling us to become a fully integrated diagnostics company.

We have a pipeline of single test (singleplex) and multi-test (multiplex) specific, diagnostic solutions for a wide range of human diseases. We have built our product candidate portfolio through internal discovery and are advancing our product candidates through in-house R&D. Utilizing a unique data-driven set of design rules, algorithms and processes, we develop tests intelligently instead of by the prevailing trial and error approach. Such systems and processes enable IntelligentMDx to develop tests in a fraction of the time, driving early market penetration and prolonging test life cycles.

Our IntelligentMDx test development process is composed of four integrated modules: PreMD™, PriMD™, MetaMD™ and ProMD™. The quality and breadth of our product candidate pipeline, platform-agnostic approach, scientific team and strategic collaborations is enabling us to become a fully integrated diagnostics company.